SUMMARY Twenty four hour intragastric acidity and nocturnal acid output have been measured over five separate 24 hour periods in each of 12 patients with duodenal ulcer receiving either placebo, cimetidine 400 mg bd, cimetidine 300 mg nocte, ranitidine 150 mg bd, or ranitidine 300 mg nocte. In these doses ranitidine was significantly more effective at decreasing intragastric acidity and nocturnal acid output than cimetidine. There was no significant difference between twice daily ranitidine and night time ranitidine or between twice daily cimetidine and night time cimetidine in the reduction of intragastric acidity. Nocturnal acid output was controlled significantly better with ranitidine at night, twice daily dosage of ranitidine, and cimetidine at night, than by the twice daily dosage of cimetidine. It is suggested that a single nocturnal dose of cimetidine or ranitidine should be evaluated in a clinical trial. 
Cimetidine was introduced in the United Kingdom for the treatment of duodenal ulcer with a recommended dose of 200 mg tds and 400 mg nocte (1 g/day).' More recently a dose of 400 mg bd has been shown to be equally effective at lowering intragastric acidity2 and ulcer healing.3 4 Ranitidine is also recommended in a twice daily dose of 150 mg for ulcer healing5 6 and both of these drugs have been given effectively as a single night time dose to prevent ulcer relapse.7 8 Measures which decrease intragastric acidity over a 24 hour period are known to result in ulcer healing.9 10 Dragstedt suggested that nocturnal hypersecretion was the most important single factor in the pathogenesis of duodenal ulcer"l and we have recently shown that although there is little variation in an individual's response to cimetidine during the daytime, overnight, patients who show a poor clinical response to cimetidine treatment also show little decrease in hydrogen ion (H') activity. 12 These data and our knowledge that a single night time dose of an H2 receptor antagonist can prevent duodenal ulcer relapse, suggest that a larger dose, may be effective primary treatment. During the daytime food partially buffers intragastric acidity and therefore a morning dose of drug may be unnecessary. To investigate this hypothesis, we have studied intragastric acidity over a 24 hour period comparing twice daily ranitidine with twice daily cimetidine and both drugs given as a single large bedtime dose.
Methods

PATIENTS
Twelve patients with an endoscopically proven duodenal ulcer in remission were each studied over five separate 24 hour periods receiving either placebo, cimetidine 400 mg bd, ranitidine 150 mg bd, cimetidine 800 mg nocte, or ranitidine 300 mg nocte. Treatments were randomised, taken single blind and administered at 2100 on the day before the study and at 0900 and 2100 on the study day for the twice daily dosage, and at 2100 on the study day for the once daily regimen. All subjects gave their informed consent and the study was approved by the Hospital Ethical Committee.
The Blackwood and Northfield18 showed that although .antly more cimetidine 800 mg had an increased and more i cimetidine prolonged effect on intragastric pH than the 400 mg t difference dose both these regimens inhibit nocturnal acid night time output by a similar degree (92.7% and 94.2% respectively). This degree of acid inhibition is much greater than our report in patients showing a poor clinical response to treatment19 when we failed to observe a significantly greater effect after increasing CtiVity were the dose of cimetidine from 1 g/day to 2 g/day. bd than by Maintenance therapy with cimetidine 800 mg nitidine 300 nocte has been shown to have a lower relapse rate than with the 400 mg dose17 and Fitzpatrick et al have suggested that maintenance therapy with cimetidine 400 mg nocte has mainly an antacid effect whereas cimetidine 800 mg nocte results in a real reduction of relapse rate. 21 Cimetidine and ranitidine may increase serum prolactin22 23 and by using a large nocturnal dose the risk of prolactin release might be increased in some patients. A total daily dose of cimetidine 800 mg nocte, however, is less than the 1 g/day originally recommended for cimetidinel and while using an 800 mg nocte dose for maintenance therapy, Blackwood et al reported no adverse events.20 In addition, Burland et a124 found no increase in serum prolactin after an 800 mg dose of cimetidine in healthy subjects.
On placebo, H' activity was lower during the daytime than during the overnight period which is when patients classically complain of pain relieved by food. Food buffering is more physiological than pharmacological control of acid secretion and the morning dose of an H2 receptor antagonist may therefore be unnecessary.
If the concept of 'no acid no ulcer' is correct,25 using a large single nocturnal dose of either cimetidine or ranitidine provides practical as well as theoretical advantages; patients would find a single dose more convenient and acceptable and compliance is likely to be better. Our study has shown that a single night time dose of an H2 receptor antagonist is as effective as a twice daily regimen of these drugs in reducing H' activity and acid output and we suggest that a large single nocturnal dose of treatment be evaluated by clinical trial. This is the second in the series of a compilation of original papers that have been selected and abstracted by two distinguished American gastroenterologists, one a physician and the other a surgeon. Each paper is reduced to a summary of the original paper, sometimes accompanied by a key Table or Figure, and followed by a comment from one of the editors. The layout, typography, and indexing are excellent, and make this a very easy way to keep up with what has been going on across the spectrum of clinical gastroenterology.
In no way can this anthology be described as comprehensive; the reduction of a year's publishing output to 250 papers inevitably reflects personal choice and national preoccupations. Others might choose differently -I would like to have seen the inclusion of more pathophysiology -but the book gains precisely because it is a personal selection, and is enlivened by the incisive and critical comments of the authors. It is a pity it is so expensive, at least for British gastroenterologists. 
